~~<i id='FE8CE883EF'><strike id='FE8CE883EF'><tt id='FE8CE883EF'><pre id='FE8CE883EF'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：hotspot 2025-09-28 14:43:54 Page View：45959

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Senate panel clears PBM, hopsital reforms
Next article： Supreme Court strikes down use of affirmative action

comprehensive

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

PascalSoriot,thechiefexecutiveofficerofAstraZeneca.WinMcNamee/GettyImagesTheparticipantwhotriggereda

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Will General Catalyst be the first of many hospital takeovers?

AdobeGeneralCatalyst’splantotakeoverahospitalinthecomingmonthscouldbethefirstofmanysuchdeals,drivenb